During the past decade, Ondokuz Mayis Univ. Med. Fac. conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 15 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 11 clinical trials were completed. i.e. 73.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ondokuz Mayis Univ. Med. Fac." #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Celgene" with 3 trials sponsored, "Abbott Nutrition" with 2 trials sponsored, "Alexion" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ondokuz Mayis Univ. Med. Fac." #1 collaborator was "Chugai Pharmaceutical" with 4 trials as a collaborator, "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator, "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Janssen Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ondokuz Mayis Univ. Med. Fac." are "Multiple Myeloma" (4 trials), "Multiple Sclerosis" (2 trials), "Myelofibrosis" (2 trials), "Neuromyelitis Optica" (2 trials) and "Neuromyelitis Optica Spectrum Disorder" (2 trials). Many other conditions were trialed in "Ondokuz Mayis Univ. Med. Fac." in a lesser frequency.

Most popular intervention types in "Ondokuz Mayis Univ. Med. Fac." are "Drug" (28 trials), "Biological" (7 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Dexamethasone" (4 trials), "Bortezomib" (3 trials), "Crovalimab" (3 trials) and "Daratumumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ondokuz Mayis Univ. Med. Fac." are 41 trials for "All" genders.

Currently, there are NaN active trials in "Ondokuz Mayis Univ. Med. Fac.". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Ondokuz Mayis Univ. Med. Fac., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ondokuz Mayis Univ. Med. Fac., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".